Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20446
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liew, David F L | - |
dc.contributor.author | Owen, Claire E | - |
dc.contributor.author | Buchanan, Russell R C | - |
dc.date | 2019-02-28 | - |
dc.date.accessioned | 2019-03-14T22:35:10Z | - |
dc.date.available | 2019-03-14T22:35:10Z | - |
dc.date.issued | 2019-02-28 | - |
dc.identifier.citation | European journal of cancer 2019; 111: 59-60 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/20446 | - |
dc.language.iso | eng | - |
dc.title | Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'. | - |
dc.type | Journal Article | en |
dc.identifier.journaltitle | European journal of cancer (Oxford, England : 1990) | - |
dc.identifier.affiliation | Department of Rheumatology, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.doi | 10.1016/j.ejca.2018.11.034 | - |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0001-8451-8883 | - |
dc.identifier.pubmedid | 30826657 | - |
dc.type.austin | Letter | - |
local.name.researcher | Buchanan, Russell R C | |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Rheumatology | - |
crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
crisitem.author.dept | Rheumatology | - |
crisitem.author.dept | Rheumatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.